[Prolonged release of chlorambucil and etoposide from poly-3-oxybutyrate-based microspheres]

Prikl Biokhim Mikrobiol. 2012 Nov-Dec;48(6):662-7.
[Article in Russian]

Abstract

Microspheres were obtained on the basis of poly(3-oxibutyrate) (POB) with the inclusion of the Chlorambucil and Etoposide cytostatic drugs in a polymer matrix, and the morphology, kinetics of drug release from microspheres, and the interaction between microspheres and tumor cells in vitro were studied. Data on the kinetics of drug release suggests that a prolonged release occurs by drug diffusion from the polymer matrix at the initial stage and at the expense of hydrolytic degradation of the polymer at a later stage. A study of the biocompatibility and biological activity of biopolymeric microspheres showed that chlorambucil operates actively and strongly inhibits the growth of cultured cells for a short time (24 h). Etoposide acts weaker (the percentage of cell growth suppression during 48 h does not exceed 50%), but subsequently it has a basis for the creation of new dosage forms with prolonged action of Etoposide and chlorambucil for cancer therapy.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / metabolism*
  • Antineoplastic Agents / pharmacology
  • Butyrates / chemistry*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Chlorambucil / metabolism*
  • Chlorambucil / pharmacology
  • Delayed-Action Preparations / chemistry*
  • Drug Carriers / chemistry*
  • Drug Compounding
  • Etoposide / metabolism*
  • Etoposide / pharmacology
  • Female
  • Humans
  • Inhibitory Concentration 50
  • Kinetics
  • Microscopy, Electron, Scanning
  • Microspheres
  • Particle Size
  • Polymers / chemistry*

Substances

  • Antineoplastic Agents
  • Butyrates
  • Delayed-Action Preparations
  • Drug Carriers
  • Polymers
  • Chlorambucil
  • Etoposide